Cargando…

Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli

Protein Glycan Coupling Technology (PGCT) uses purposely modified bacterial cells to produce recombinant glycoconjugate vaccines. This vaccine platform holds great potential in this context, namely due to its modular nature, the simplified production process in comparison to traditional chemical con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samaras, Jasmin J., Mauri, Marta, Kay, Emily J., Wren, Brendan W., Micheletti, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142613/ https://www.ncbi.nlm.nih.gov/pubmed/34030723 http://dx.doi.org/10.1186/s12934-021-01588-1

Ejemplares similares

Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines
por: Kay, Emily J., et al.
Publicado: (2022)

Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019)

Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
por: Passmore, Ian J., et al.
Publicado: (2019)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli
por: Kay, Emily J., et al.
Publicado: (2016)

A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice
por: Williams, Asher J., et al.
Publicado: (2023)

Modification of avian pathogenic Escherichia coli χ7122 lipopolysaccharide increases accessibility to glycoconjugate antigens
por: Smith, Alexander A., et al.
Publicado: (2022)

Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design
por: Duke, Jeremy A., et al.
Publicado: (2021)

Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice
por: Naini, Arun, et al.
Publicado: (2022)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome
por: Terra, Vanessa S., et al.
Publicado: (2022)

Glycoconjugate vaccines: classic and novel approaches
por: Adamo, Roberto
Publicado: (2021)

Carriers and Antigens: New Developments in Glycoconjugate Vaccines
por: van der Put, Robert M.F., et al.
Publicado: (2023)

Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis
por: Cuccui, Jon, et al.
Publicado: (2013)

Glycoconjugate Vaccine Containing Escherichia coli O157:H7 O-Antigen Linked with Maltose-Binding Protein Elicits Humoral and Cellular Responses
por: Ma, Zhongrui, et al.
Publicado: (2014)

In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation
por: Kämpf, Michael M, et al.
Publicado: (2015)

Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn’s Disease
por: Sivignon, Adeline, et al.
Publicado: (2015)

Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development
por: Colombo, Cinzia, et al.
Publicado: (2018)

Expanding polysaccharide–protein coupling of glycoconjugate vaccines
por: Berti, Francesco
Publicado: (2022)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia
por: Marshall, Laura E., et al.
Publicado: (2018)

Recent advances on smart glycoconjugate vaccines in infections and cancer
por: Anderluh, Marko, et al.
Publicado: (2021)

Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus
por: Di Benedetto, Roberta, et al.
Publicado: (2020)

The role of glycoconjugates as receptors for insecticidal proteins
por: Best, Hannah L, et al.
Publicado: (2023)

Proteome‐minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform
por: Zanella, Ilaria, et al.
Publicado: (2021)

Potential targets for next generation antimicrobial glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2018)

Preparation of aminoethyl glycosides for glycoconjugation
por: Šardzík, Robert, et al.
Publicado: (2010)

Pyruvate Substitutions on Glycoconjugates
por: Hager, Fiona F., et al.
Publicado: (2019)

Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection
por: Forsyth, Valerie S., et al.
Publicado: (2020)

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
por: Li, Qingjiang, et al.
Publicado: (2018)

Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine
por: Ma, Zhongrui, et al.
Publicado: (2017)

Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation
por: Pillot, Aline, et al.
Publicado: (2019)

Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases
por: Khatuntseva, E. A., et al.
Publicado: (2021)

Improving Chicken Responses to Glycoconjugate Vaccination Against Campylobacter jejuni
por: Nothaft, Harald, et al.
Publicado: (2021)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
por: Morais, Victor, et al.
Publicado: (2022)

The Amadori rearrangement as glycoconjugation method: Synthesis of non-natural C-glycosyl type glycoconjugates
por: Gallas, Katharina, et al.
Publicado: (2012)

The glycoconjugate ontology (GlycoCoO) for standardizing the annotation of glycoconjugate data and its application
por: Yamada, Issaku, et al.
Publicado: (2021)

Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins
por: Piubelli, Luciano, et al.
Publicado: (2013)

Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol
por: Fernández, Roger, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hbh3eupl3q30iie3j1ppd86isf